Peripheral Intravenous (IV) Catheter Market Size, Share, Growth and Industry Analysis, By Types (Short PIVCs, Integrated Or Closed PIVCs), By Applications (Hospitals, Clinics, ASCs), Regional Insights and Forecast to 2035

PERIPHERAL INTRAVENOUS (IV) CATHETER MARKET SIZE

The Global Peripheral Intravenous (IV) Catheter Market was valued at USD 3.73 Billion in 2025 and is projected to reach USD 3.91 Billion in 2026, further expanding to USD 4.11 Billion in 2027. The market is expected to grow steadily, reaching USD 6.02 Billion by 2035, registering a compound annual growth rate (CAGR) of 4.9% during the projected revenue period from 2026 to 2035. Market growth is driven by increasing hospital and clinical procedures, rising prevalence of chronic diseases, technological advancements in catheter materials and design, and growing awareness for safer and more efficient intravenous therapy solutions globally.

The U.S. Peripheral Intravenous (IV) Catheter market is a dominant segment, driven by advanced healthcare infrastructure, high demand for safety-engineered devices, and increasing prevalence of chronic diseases, bolstering its market share and growth prospects.

The Peripheral Intravenous (IV) Catheter market is a crucial sector in the global healthcare industry, enabling efficient and safe fluid administration, medication delivery, and blood sampling. With continuous advancements in catheter designs, materials, and ease of insertion, the market is experiencing rapid growth. The increasing number of medical procedures, an aging population, and the rising incidence of chronic diseases such as diabetes and cardiovascular conditions are fueling the demand for peripheral IV catheters. Innovations in catheter technology, including safety features and enhanced comfort, have also significantly contributed to the market's expansion in recent years.

PERIPHERAL INTRAVENOUS (IV) CATHETER MARKET TRENDS

The Peripheral Intravenous (IV) Catheter market is evolving with several notable trends, reflecting advancements in technology and changing patient needs. Increasing adoption of advanced catheters, such as safety-engineered devices that reduce the risk of needle-stick injuries, is one significant trend. Additionally, the demand for catheters with improved materials like polyurethane and silicone, which offer better durability and biocompatibility, is growing. In terms of geographical trends, North America holds a significant share due to the presence of well-established healthcare infrastructure and high healthcare spending. On the other hand, the Asia-Pacific region is witnessing rapid growth due to rising healthcare investments, expanding patient populations, and increasing awareness about the benefits of IV catheters. Another trend is the shift towards minimally invasive procedures, boosting the use of peripheral IV catheters in outpatient clinics, hospitals, and ambulatory settings. This trend is particularly notable in countries with well-developed healthcare systems. Additionally, the growing focus on patient comfort and safety has led to innovations such as catheters with smooth insertion capabilities, reducing complications and improving overall patient experience. As healthcare professionals prioritize patient well-being, these trends are expected to play a pivotal role in shaping the future of the peripheral IV catheter market.

PERIPHERAL INTRAVENOUS (IV) CATHETER MARKET DYNAMICS

The Peripheral Intravenous (IV) Catheter market is driven by dynamic factors that significantly influence its growth trajectory. A major factor is the increasing demand for efficient healthcare solutions, particularly in emergency care, chronic disease management, and surgical procedures. Hospitals, outpatient centers, and ambulatory clinics are expanding their use of peripheral IV catheters to ensure effective medication administration. Additionally, innovations in catheter technology, such as needleless IV catheter systems and improved insertion techniques, have enhanced patient safety, reducing complications like phlebitis and infections. Another important dynamic is the rise in the aging population, which increases the prevalence of conditions requiring regular intravenous therapy, including cancer, diabetes, and cardiovascular diseases. Furthermore, healthcare systems across the globe are emphasizing patient-centered care, prompting demand for more comfortable and safer medical devices, including peripheral IV catheters. The increase in the number of surgeries, coupled with rising outpatient treatments, further strengthens the market. However, challenges related to device-related infections and the increasing demand for healthcare professionals trained in catheter insertion and management are influencing the market's development. Despite these challenges, the continuous improvement in technology and innovations are expected to ensure the steady expansion of the peripheral IV catheter market.

Drivers of Market Growth

"Growing Prevalence of Chronic Diseases"

The rise in chronic diseases such as diabetes, cardiovascular conditions, and cancer is a significant driver for the growth of the peripheral IV catheter market. As these conditions often require long-term intravenous medication and therapy, the demand for peripheral IV catheters is increasing. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, and the prevalence of diabetes has nearly quadrupled since 1980. With more patients needing regular intravenous interventions, healthcare providers are relying on IV catheters to administer medication and fluids safely and efficiently.

Market Restraints

"Limited Awareness and Training for Healthcare Providers"

A notable restraint in the peripheral IV catheter market is the limited awareness and training available for healthcare professionals regarding the proper use and maintenance of IV catheters. Improper insertion techniques and insufficient knowledge about catheter care can lead to complications such as infections and thrombophlebitis, ultimately affecting patient safety. Despite the growth in healthcare investments, especially in emerging markets, there is still a shortage of adequately trained healthcare providers in some regions. This gap poses a significant barrier to the efficient use of IV catheters, limiting their adoption and increasing the risk of adverse patient outcomes.

Market Opportunities

"Technological Advancements in Catheter Design"

Technological innovations in the design of peripheral IV catheters present significant opportunities for market growth. For instance, the development of catheters with anti-microbial coatings, easier insertion technologies, and safety-engineered designs that reduce the risk of needle-stick injuries offer substantial advantages. Additionally, the trend toward minimally invasive procedures is driving the demand for IV catheters that minimize patient discomfort. As healthcare providers increasingly prioritize patient safety and comfort, manufacturers are exploring new materials and technologies that enhance catheter performance. These innovations open up new market opportunities, particularly in developed healthcare systems where patient care quality is a high priority.

Market Challenges

"Risk of Infections and Device Failures"

A major challenge for the peripheral IV catheter market is the potential risk of infections and device failures, which can compromise patient safety. Catheter-related bloodstream infections (CRBSIs) are a serious concern, especially in immunocompromised patients. Despite advancements in catheter technology, the risk of infections remains prevalent, particularly in long-term catheter placements. Complications like thrombosis, phlebitis, and occlusions also pose challenges for both healthcare providers and patients. The need for regular monitoring and the maintenance of proper hygiene practices is essential, adding complexity to the administration of IV therapy and placing additional burden on healthcare systems worldwide.

SEGMENTATION ANALYSIS

The peripheral intravenous (IV) catheter market can be segmented based on type and application, with each segment showing varying growth patterns. By type, the market is divided into short PIVCs and integrated or closed PIVCs, each offering specific benefits suited for different patient needs. In terms of application, the market is categorized into hospitals, clinics, and ambulatory surgical centers (ASCs). The use of peripheral IV catheters in these settings differs, driven by factors such as patient volume, medical procedure types, and the need for specialized care. These segmentations allow for a clearer understanding of the market’s demand and growth prospects.

By Type

• Short PIVCs are one of the most commonly used types of peripheral IV catheters. These catheters are typically inserted into veins near the surface of the skin and are ideal for short-term intravenous therapy, often ranging from a few hours to a few days. The short PIVCs segment is seeing strong growth due to the increasing number of outpatient procedures and hospitalizations. Hospitals frequently use short PIVCs for quick infusion of fluids and medications in emergency or acute care settings. The convenience, simplicity, and effectiveness of these catheters in short-term applications are contributing to their widespread adoption globally.

• Integrated or Closed PIVCs offer advanced safety features and are designed to minimize the risk of catheter-related bloodstream infections (CRBSIs). These devices come with built-in safety mechanisms such as automatic closures that reduce exposure to needles and prevent contamination. Integrated PIVCs are commonly used in both hospitals and outpatient settings where infection prevention is a priority. They are particularly in demand in intensive care units (ICUs) and surgical units. The increasing focus on patient safety and reducing hospital-acquired infections is driving the adoption of integrated or closed PIVCs, making them an important segment in the global peripheral IV catheter market.

By Application

• Hospitals, Clinics, ASCs:The hospitals segment dominates the peripheral IV catheter market, driven by the large number of patients requiring intravenous therapy. Hospitals use these devices extensively for patients undergoing surgery, intensive care, or chronic disease treatment. The clinics segment is growing as more outpatient procedures requiring short-term IV therapy become common. The demand for peripheral IV catheters in ambulatory surgical centers (ASCs) is also on the rise, as these centers provide outpatient surgical services that often require IV access. The broad use of peripheral IV catheters in these applications reflects the increasing need for efficient, safe, and cost-effective IV solutions in diverse healthcare settings.

REGIONAL INSIGHTS

The regional outlook for the peripheral intravenous (IV) catheter market varies significantly across regions, driven by differences in healthcare infrastructure, patient demographics, and local healthcare needs. North America leads the market due to its advanced healthcare systems and high patient volumes. Europe also represents a strong market for IV catheters, with an emphasis on safety features and innovation. The Asia-Pacific region is expected to see rapid growth, spurred by the increasing population, rising healthcare investments, and improving access to medical devices. The Middle East and Africa are emerging markets, where the growing healthcare sector is expected to increase demand for IV catheters.

North America 

North America holds a significant share of the peripheral IV catheter market due to its advanced healthcare infrastructure, high healthcare spending, and a well-established medical device industry. The United States, in particular, is a major contributor, with hospitals and healthcare facilities increasingly adopting advanced peripheral IV catheter technologies to improve patient safety and treatment outcomes. The rising prevalence of chronic diseases, such as diabetes and heart conditions, further drives demand. Additionally, healthcare providers in North America prioritize reducing hospital-acquired infections, which boosts the adoption of safety-engineered and closed-system catheters, thus contributing to market growth in the region.

Europe

Europe is a key market for peripheral intravenous (IV) catheters, with countries such as Germany, France, and the UK showing high demand. The European market is driven by a focus on patient safety, stringent regulatory standards, and widespread healthcare infrastructure. The increasing adoption of advanced IV catheter technologies, including safety-engineered and closed-loop systems, is particularly prominent in hospitals and outpatient clinics. Additionally, Europe's aging population and the rising prevalence of chronic diseases contribute to a higher demand for intravenous therapies. The emphasis on minimizing healthcare-associated infections in European healthcare systems further boosts the market for these catheters.

Asia-Pacific

The Asia-Pacific region is witnessing rapid growth in the peripheral IV catheter market, driven by increasing healthcare investments and improving medical infrastructure. Countries like China and India are experiencing significant market expansion due to the growing population, higher incidence of chronic diseases, and the need for more advanced healthcare solutions. The increasing number of surgeries, outpatient treatments, and healthcare facilities in these countries is fueling demand for peripheral IV catheters. Furthermore, rising awareness about the benefits of safety-engineered IV catheters and the expansion of medical insurance coverage are contributing factors to the market’s growth in the Asia-Pacific region.

Middle East & Africa

The Middle East & Africa (MEA) region is showing substantial growth in the peripheral IV catheter market, primarily driven by improving healthcare infrastructure, rising disposable income, and an increase in medical tourism. Countries like the United Arab Emirates, Saudi Arabia, and South Africa are investing heavily in healthcare advancements, which is contributing to the increased demand for medical devices like peripheral IV catheters. As hospitals and clinics continue to modernize their facilities and adopt advanced technologies, the need for efficient and safe IV solutions grows. Despite challenges related to healthcare accessibility in some areas, the MEA market is on an upward trajectory.

LIST OF KEY PERIPHERAL INTRAVENOUS (IV) CATHETER MARKET COMPANIES PROFILED

• B. Braun Melsungen
• C.R. Bard
• Smiths Medical
• TERUMO CORPORATION
• AngioDynamics
• APEXMED International
• Delta Med
• EXELINT International
• GaltNeedleTech
• Global Medikit
• Hospira
• NIPRO Medical
• RenovoRx

Top 2 Companies with Highest Market Share

1. B. Braun Melsungen: B. Braun Melsungen is one of the largest players in the market, holding a dominant market share. The company is known for its wide range of IV catheters, including safety-engineered models, and has a global presence across North America, Europe, and Asia.

2. C.R. Bard: C.R. Bard is another major player in the IV catheter market, with an extensive portfolio of vascular access products. The company has a strong market presence due to its innovative catheter designs and focus on improving patient safety.

INVESTMENT ANALYSIS AND OPPORTUNITIES

The peripheral intravenous (IV) catheter market presents several investment opportunities driven by innovations in medical technology, increasing demand for safer and more effective devices, and the expansion of healthcare infrastructure in emerging markets. The demand for advanced IV catheters, especially those with integrated safety features like needleless systems and antimicrobial coatings, is expected to continue growing. Companies are investing heavily in research and development (R&D) to create next-generation catheters that reduce the risk of infection and enhance patient comfort. In addition, investments in expanding production facilities in regions like Asia-Pacific, where healthcare spending is increasing rapidly, are likely to offer substantial returns. Moreover, the aging population in developed countries and the rise in chronic diseases, such as cardiovascular and diabetes, are boosting the need for frequent intravenous therapies, thereby creating long-term opportunities. Healthcare providers are also increasingly adopting peripheral IV catheters in outpatient settings, ambulatory surgical centers (ASCs), and home healthcare, which opens new markets for manufacturers. Additionally, there is an ongoing effort to make IV catheter systems more user-friendly, providing opportunities for manufacturers who can address the pain points faced by healthcare professionals and patients. Overall, these factors make the peripheral IV catheter market a promising area for continued investment.

NEW PRODUCTS DEVELOPMENT

The peripheral intravenous (IV) catheter market is seeing significant advancements in product development aimed at improving patient safety, reducing the risk of infections, and enhancing the overall user experience. Recent developments include the introduction of safety-engineered IV catheters that prevent needle-stick injuries and reduce the potential for contamination. Companies are incorporating anti-microbial coatings into catheters to prevent catheter-related infections, a major concern in clinical settings. For example, B. Braun Melsungen and TERUMO CORPORATION have developed new versions of their IV catheters with enhanced safety features and improved ease of insertion, allowing healthcare professionals to better manage patients’ intravenous needs. Additionally, innovation in materials has led to the development of catheters that are more flexible, durable, and easier to insert, minimizing discomfort for patients. These products are gaining traction in the market as they offer better outcomes and reduce the risk of complications. Furthermore, several manufacturers are focusing on creating closed or integrated IV catheter systems that reduce the risk of exposure to bloodborne pathogens. These innovations are helping healthcare facilities improve infection control practices, which are becoming more stringent globally. The demand for such advanced solutions is expected to drive continued growth in the peripheral IV catheter market.

RECENT DEVELOPMENTS

• B. Braun Melsungen: In 2023, B. Braun launched a new range of IV catheters designed with enhanced safety features, including automatic locking mechanisms that prevent accidental needlestick injuries.

• TERUMO CORPORATION: In 2023, TERUMO introduced an advanced IV catheter with an integrated antimicrobial coating to help prevent catheter-related infections, addressing growing concerns about healthcare-associated infections.

• Smiths Medical: In 2024, Smiths Medical released an updated version of its IV catheter that uses a new material blend, improving both patient comfort and catheter durability.

• AngioDynamics: In 2024, AngioDynamics launched a closed-system IV catheter to reduce the risk of exposure to bloodborne pathogens, a critical need in the healthcare industry.

• NIPRO Medical: In 2023, NIPRO Medical expanded its product line with IV catheters designed for both pediatric and adult patients, offering safer insertion techniques and flexible materials that enhance patient comfort during long-term treatments.

REPORT COVERAGE

The report on the peripheral intravenous (IV) catheter market offers a comprehensive analysis of key trends, growth drivers, challenges, and opportunities shaping the market's future. It provides in-depth insights into various market segments, including by type (short PIVCs, integrated or closed PIVCs) and application (hospitals, clinics, ASCs). The report covers regional dynamics, highlighting key markets in North America, Europe, Asia-Pacific, and the Middle East & Africa. It explores the competitive landscape, profiling leading companies such as B. Braun Melsungen, C.R. Bard, Smiths Medical, and TERUMO CORPORATION. Furthermore, it assesses technological innovations and new product developments within the market, showcasing recent advancements in safety-engineered IV catheters and antimicrobial coatings. The report also analyzes investment opportunities and challenges faced by manufacturers in a rapidly evolving healthcare environment. Additionally, it provides a detailed examination of market restraints, including issues related to healthcare infrastructure and the need for better healthcare training. By focusing on both established and emerging markets, the report delivers a balanced view of the current and future state of the peripheral IV catheter market, helping stakeholders make informed decisions. With detailed market insights, product analyses, and growth forecasts, this report is an essential resource for investors and businesses seeking to understand the market landscape.